WALTHAM, Mass. , Aug. 29, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) today reported that it will be both exhibiting and sponsoring a diabetic neuropathy symposium at the 28th Annual Meeting of NEURODIAB held in Rome, Italy September 4-7 .
Quell ™ Wearable Pain Relief and DPNCheck ® Neuropathy Test to be Featured WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians better manage chronic
Will Feature SENSUS Pain Management System and DPNCheck Peripheral Neuropathy Test WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic
Malvern (U.K.) Diabetic Foot Conference on May 14-16, 2014 WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases,
NeuroMetrix To Exhibit at Medtrade Tradeshow and Conference WALTHAM, Mass. --(BUSINESS WIRE)--Sep. 30, 2013-- NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the treatment and management of chronic pain, peripheral neuropathies, and related neurological disorders, today